Abstract
The muscle toxicity caused by injection of various poloxamer vehicles into the M. vastus lateralis of rabbits was investigated in single and multiple dose studies via gross morphological examination of the muscle tissue and by monitoring creatine phosphokinase (CPK) levels as a function of time following injection. Results were compared to those obtained for currently accepted intramuscular (IM) vehicles such as normal saline, cremophor EL, and peanut oil. The toxicity of the poloxamer vehicles was proportional to their lipophilicity; the more lipophilic the poloxamer, the more severe the lesion produced following injection and the greater the elevation in plasma CPK. Based on this preliminary study, it appears that poloxamer 407 and 238 may be suitable polymers for incorporation into vehicles for use as injectable gels for prolonged drug delivery.
- Received October 8, 1984.
- Accepted January 10, 1985.
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.